UPCC 43419: Prospective Study of Immune Biomarkers in Patients with Multiple Myeloma
Brief description of study
The objective of this exploratory observational cohort study is to obtain blood samples - and in some cases, bone marrow aspirate samples - from patients with multiple myeloma for study in the laboratory.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
myeloma
-
Age: - 99 Years
-
Gender: All
Updated on
09 Mar 2024.
Study ID: 834039
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com